Regional analysis of a cohort compassionate-use program and early access program with cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mcrpc) previously treated with docetaxel
Fecha de publicación
2015Título de revista
Asia-Pacific Journal of Clinical Oncology
Tipo de contenido
Publicación de congreso